www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Spectranetics-Reports-Record-Fourth-Quarter-Revenue-Up-11-to-29-7-Million-744529 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft3 {padding-left: 15.0px} .bwcellpaddingleft6 {padding-left: 30.0px} .bwcellpaddingright0 ...http://www.finanzen.net/nachricht/Spectranetics-Reports-Record-Fourth-Quarter-Revenue-Up-11-to-29-7-Million-744529http://www.finanzen.net/nachricht/Spectranetics-to-Hold-2009-Fourth-Quarter-Financial-Results-Conference-Call-on-February-18-739771 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <b>Spectranetics Corporation (Nasdaq: SPNC)</b> today announced that the Company will release 2009 fourth quarter financial results prior to ...http://www.finanzen.net/nachricht/Spectranetics-to-Hold-2009-Fourth-Quarter-Financial-Results-Conference-Call-on-February-18-739771http://www.finanzen.net/nachricht/Journal-of-American-College-of-Cardiology-Publishes-Study-Demonstrating-Safety-Effectiveness-of-Laser-Assisted-Lead-Removal-736061 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> <!-- sh_cad_1 --> Spectranetics Corporation (NASDAQ: SPNC) today announced publication of the ...http://www.finanzen.net/nachricht/Journal-of-American-College-of-Cardiology-Publishes-Study-Demonstrating-Safety-Effectiveness-of-Laser-Assisted-Lead-Removal-736061http://www.finanzen.net/nachricht/Published-Study-Demonstrates-Effectiveness-of-Spectranetics-Turbo-Booster-for-Peripheral-Artery-Disease-726421 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> <!-- sh_cad_1 --> Spectranetics Corporation (NASDAQ: SPNC) today announced publication of the CELLO ...http://www.finanzen.net/nachricht/Published-Study-Demonstrates-Effectiveness-of-Spectranetics-Turbo-Booster-for-Peripheral-Artery-Disease-726421http://www.finanzen.net/nachricht/Spectranetics-Announces-Resolution-of-Federal-Investigation-721088 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwtextalignleft {text-align: left} --> </style> <!-- sh_cad_1 --> <a href="/aktien/Spectranetics-Aktie">Spectranetics</a> Corporation ("Company”) (Nasdaq:SPNC) today reported ...http://www.finanzen.net/nachricht/Spectranetics-Announces-Resolution-of-Federal-Investigation-721088http://www.finanzen.net/nachricht/Spectranetics-Announces-FDA-Clearance-of-VisiSheath-Dilator-Sheath-New-Lead-Management-Device-711090 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Spectranetics Corporation (Nasdaq: SPNC) today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheath^TM ...http://www.finanzen.net/nachricht/Spectranetics-Announces-FDA-Clearance-of-VisiSheath-Dilator-Sheath-New-Lead-Management-Device-711090http://www.finanzen.net/nachricht/Spectranetics-to-Present-at-the-Canaccord-Adams-3rd-Annual-Cardiovascular-Conference-on-November-10-695927 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <b>Spectranetics Corporation (Nasdaq: SPNC)</b> today announced that it will present at the Canaccord Adams 3^rd Annual Cardiovascular ...http://www.finanzen.net/nachricht/Spectranetics-to-Present-at-the-Canaccord-Adams-3rd-Annual-Cardiovascular-Conference-on-November-10-695927http://www.finanzen.net/nachricht/Spectranetics-Reports-Third-Quarter-Revenue-Up-7-to-28-8-Million-691108 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft2 {padding-left: 10.0px} .bwcellpaddingleft4 {padding-left: 20.0px} .bwcellpaddingleft8 ...http://www.finanzen.net/nachricht/Spectranetics-Reports-Third-Quarter-Revenue-Up-7-to-28-8-Million-691108http://www.finanzen.net/nachricht/Spectranetics-to-Hold-2009-Third-Quarter-Financial-Results-Conference-Call-on-October-28-687436 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <b>Spectranetics Corporation (Nasdaq:SPNC)</b> today announced that the Company will release 2009 third quarter financial results prior to market ...http://www.finanzen.net/nachricht/Spectranetics-to-Hold-2009-Third-Quarter-Financial-Results-Conference-Call-on-October-28-687436http://www.finanzen.net/nachricht/Spectranetics-Submits-510-k-Application-to-Food-and-Drug-Administration-Seeking-Clearance-for-the-Treatment-of-In-Stent-Restenosis-in-the-Legs-676660 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Spectranetics-Aktie">Spectranetics</a> Corporation (Nasdaq: SPNC) today announced that it has filed a 510(k) application with the ...http://www.finanzen.net/nachricht/Spectranetics-Submits-510-k-Application-to-Food-and-Drug-Administration-Seeking-Clearance-for-the-Treatment-of-In-Stent-Restenosis-in-the-Legs-676660